Andreas Wicki, Director at Pacira BioSciences, Inc. (PCRX), sold 396,852 shares at $61.47 ($24.3M) on 2020-08-13, disclosed to the SEC on 2020-08-13.
Open-market sale of $24.3M PCRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.87 | 60,621 | $3.7M | 15.2% |
| 2 | $60.87 | 60,621 | $3.7M | 15.2% |
| 3 | $61.90 | 46,151 | $2.9M | 11.8% |
| 4 | $61.90 | 46,151 | $2.9M | 11.8% |
| 5 | $60.82 | 113,500 | $6.9M | 28.4% |
| 6 | $61.47 | 34,904 |
| $2.1M |
| 8.8% |
| 7 | $61.47 | 34,904 | $2.1M | 8.8% |
| Total | $61.20 avg | 396,852 | $24.3M | 100% |
| Filing → |
| HRMY | SELL | 2022-11-16 | $6.1M | — | Filing → |
| HRMY | SELL | 2022-11-10 | $15.2M | — | Filing → |
| HRMY | SELL | 2022-11-04 | $68.2M | — | Filing → |